Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Wirth

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Nutrition and Cancer|June 28, 2016
Early and Intensive Dietary Counseling in Lung Cancer Patients Receiving (Chemo)Radiotherapy-A Pilot Randomized Controlled TrialNicole Kiss, Elisabeth Isenring, Karla Gough, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2015
Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology GroupJoachim Yahalom, Tim Illidge, Lena Specht, et al.
Leukemia & Lymphoma|October 2, 2012
Efficacy of low dose radiotherapy for primary orbital marginal zone lymphomaKrystel H Tran, Belinda A Campbell, Tsien Fua, et al.
Blood Advances|October 9, 2021
Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCLJemima H Miller, Michael Gilbertson, Michael P MacManus, et al.
Acta Oncologica (Stockholm, Sweden)|April 1, 2003
FDG-PET-detected extracranial metastasis in patients with non-small cell lung cancer undergoing staging for surgery or radical radiotherapy--survival correlates with metastatic disease burdenMichael R MacManus, Rodney Hicks, Richard Fisher, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2010
Limited chemotherapy and shrinking field radiotherapy for Osteolymphoma (primary bone lymphoma): results from the trans-Tasman Radiation Oncology Group 99.04 and Australasian Leukaemia and Lymphoma Group LY02 prospective trialDavid Christie, Keith Dear, Thai Le, et al.
Cancer|January 25, 2006
Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancerMichael P Mac Manus, Jane P Matthews, Morikatsu Wada, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2018
Outcome of patients with early-stage follicular lymphoma staged with <sup>18</sup>F-Fluorodeoxyglucose (FDG) positron emission tomography (PET) and treated with radiotherapy aloneSweet Ping Ng, Richard Khor, Mathias Bressel, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failureMichael P Mac Manus, Rodney J Hicks, Jane P Matthews, et al.
International Journal of Radiation Oncology, Biology, Physics|March 2, 2002
Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral centerMichael P Mac Manus, Kevin Wong, Rodney J Hicks, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Nutrition and Cancer|June 28, 2016
Early and Intensive Dietary Counseling in Lung Cancer Patients Receiving (Chemo)Radiotherapy-A Pilot Randomized Controlled TrialNicole Kiss, Elisabeth Isenring, Karla Gough, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2015
Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology GroupJoachim Yahalom, Tim Illidge, Lena Specht, et al.
Leukemia & Lymphoma|October 2, 2012
Efficacy of low dose radiotherapy for primary orbital marginal zone lymphomaKrystel H Tran, Belinda A Campbell, Tsien Fua, et al.
Blood Advances|October 9, 2021
Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCLJemima H Miller, Michael Gilbertson, Michael P MacManus, et al.
Acta Oncologica (Stockholm, Sweden)|April 1, 2003
FDG-PET-detected extracranial metastasis in patients with non-small cell lung cancer undergoing staging for surgery or radical radiotherapy--survival correlates with metastatic disease burdenMichael R MacManus, Rodney Hicks, Richard Fisher, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2010
Limited chemotherapy and shrinking field radiotherapy for Osteolymphoma (primary bone lymphoma): results from the trans-Tasman Radiation Oncology Group 99.04 and Australasian Leukaemia and Lymphoma Group LY02 prospective trialDavid Christie, Keith Dear, Thai Le, et al.
Cancer|January 25, 2006
Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancerMichael P Mac Manus, Jane P Matthews, Morikatsu Wada, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 8, 2018
Outcome of patients with early-stage follicular lymphoma staged with <sup>18</sup>F-Fluorodeoxyglucose (FDG) positron emission tomography (PET) and treated with radiotherapy aloneSweet Ping Ng, Richard Khor, Mathias Bressel, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failureMichael P Mac Manus, Rodney J Hicks, Jane P Matthews, et al.
International Journal of Radiation Oncology, Biology, Physics|March 2, 2002
Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral centerMichael P Mac Manus, Kevin Wong, Rodney J Hicks, et al.
Pageof 8